Page last updated: 2024-11-04

sulfadiazine and Metabolic Diseases

sulfadiazine has been researched along with Metabolic Diseases in 2 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shao, Z1
Wang, S1
Liu, N1
Wang, W1
Zhu, L1
Sekas, G1
Paul, HS1

Other Studies

2 other studies available for sulfadiazine and Metabolic Diseases

ArticleYear
Interactions between sulfonamide homologues and glycosyltransferase induced metabolic disorders in rice (Oryza sativa L.).
    Environmental pollution (Barking, Essex : 1987), 2023, Nov-01, Volume: 336

    Topics: Glycosyltransferases; Metabolic Diseases; Molecular Docking Simulation; Oryza; Sugars; Sulfadiazine;

2023
Hyperammonemia and carnitine deficiency in a patient receiving sulfadiazine and pyrimethamine.
    The American journal of medicine, 1993, Volume: 95, Issue:1

    Topics: Adult; Ammonia; Carnitine; Drug Therapy, Combination; Humans; Male; Metabolic Diseases; Pyrimethamin

1993